Clinical Trial Update: Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing tigecycline with levofloxacin in adults hospitalized with community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Tigecycline (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Community-Acquired Infections, Bacterial Pneumonia | Phase 3 | Status: COMPLETED